Amino acid substitutions in the H5N1 avian influenza haemagglutinin alter pH of fusion and receptor binding to promote a highly pathogenic phenotype in chickens by Sealy, Joshua E. et al.
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Sealy, Joshua E., Howard, Wendy A., Molesti, Eleonora, Iqbal, Munir, Temperton, Nigel J., Banks,
Jill, Slomka, Marek J., Barclay, Wendy S. and Long, Jason S.   (2021) Amino acid substitutions
in the H5N1 avian influenza haemagglutinin alter pH of fusion and receptor binding to promote
a highly pathogenic phenotype in chickens.   Journal of General Virology, 102  (11).    ISSN 0022-1317.
DOI
https://doi.org/10.1099/jgv.0.001672





Amino acid substitutions in the H5N1 avian influenza 
haemagglutinin alter pH of fusion and receptor binding to 
promote a highly pathogenic phenotype in chickens
Joshua E. Sealy1, Wendy A. Howard2, Eleonora Molesti3,4, Munir Iqbal1, Nigel J. Temperton3, Jill Banks2, Marek J. Slomka2, 
Wendy S. Barclay5 and Jason S. Long2,5,6,*
RESEARCH ARTICLE
Sealy et al., Journal of General Virology 2021;102:001672
DOI 10.1099/jgv.0.001672
Received 07 June 2021; Accepted 13 August 2021; Published 02 November 2021
Author affiliations: 1Avian Influenza Group, The Pirbright Institute, Woking, GU24 0NF, UK; 2Virology Department, Animal and Plant Health Agency 
(APHA- Weybridge), Woodham Lane, Addlestone, Surrey KT15 3NB, UK; 3Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, UK; 
4VisMederi Research S.r.l., Siena, Italy; 5Department of Infectious Disease, Faculty of Medicine, Imperial College London, St. Mary’s Campus, London W2 
1NY, UK; 6Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar EN6 3QG, UK.
*Correspondence: Jason S. Long,  Jason. long@ nibsc. org
Keywords: avian influenza; H5N1; pathogenicity ; haemagglutinin ; influenza; fusion.
Abbreviations: AIV, avian influenza virus; CEF, chicken embyo fibroblast; GsGd, Goose/Guangdong; HA, haemagglutinin; HP, high pathogenic; IVPI, 
intravenous pathogenicity index; LP, low pathogenic; MBCS, multi- basic cleavage site; NA, neuraminidase; RG, reverse genetics; SA, sialic acid; SPF, 
specific pathogen free.
One supplementary figure is available with the online version of this article.
001672 © 2021 Crown Copyright.
This is an open- access article distributed under the terms of the Creative Commons Attribution License.
Abstract
Highly pathogenic H5N1 avian influenza viruses cause devastating outbreaks in farmed poultry with serious consequences 
for animal welfare and economic losses. Zoonotic infection of humans through close contact with H5N1 infected birds is often 
severe and fatal. England experienced an outbreak of H5N1 in turkeys in 1991 that led to thousands of farmed bird mortalities. 
Isolation of clonal populations of one such virus from this outbreak uncovered amino acid differences in the virus haemag-
glutinin (HA) gene whereby the different genotypes could be associated with distinct pathogenic outcomes in chickens; both 
low pathogenic (LP) and high pathogenic (HP) phenotypes could be observed despite all containing a multi- basic cleavage site 
(MBCS) in the HA gene. Using reverse genetics, three amino acid substitutions in HA were examined for their ability to affect 
pathogenesis in the chicken. Restoration of amino acid polymorphisms close to the receptor binding site that are commonly 
found in H5 viruses only partially improved viral fitness in vitro and in vivo. A third novel substitution in the fusion peptide, 
HA
2
G4R, enabled the HP phenotype. HA
2
G4R decreased the pH stability of HA and increased the pH of HA fusion. The substitu-
tions close to the receptor binding site optimised receptor binding while modulating the pH of HA fusion. Importantly, this study 
revealed pathogenic determinants beyond the MBCS.
INTRODUCTION
Avian influenza viruses (AIVs) that carry a highly pathogenic 
(HP) phenotype are thought to have caused disease outbreaks 
recorded in gallinaceous poultry since as early as 1878 [1, 2]. 
However, only in recent decades have HPAIVs such as the 
H5N1 subtype attracted concern as regards zoonotic infec-
tions because of their high case fatality rate and the persistent 
threat posed from infected chickens and ducks [3, 4]. Human 
infection caused by the ‘goose/Guangdong’ (GsGd) lineage 
H5N1 first occurred in 1997 in Hong Kong SAR followed by 
re- emergence in 2003 in mainland China, followed by subse-
quent endemicity in poultry in the Western Pacific and South- 
East Asian regions [5, 6]. Since then, these GsGd viruses 
have continued to cause zoonotic outbreaks, primarily in the 
Western Pacific and South- East Asian regions, but also spread 
through the European, Eastern Mediterranean, and African 
regions [7–10]. Following subsequent reassortment events 
affecting the neuraminidase (NA) and viral internal genes, 
currently circulating H5Nx viruses derived from the GsGd 
lineage have evolved into descendant clades and continue to 
be disseminated by wild birds with subsequent transmission 
risks to poultry and zoonotic concerns [3, 11–14].
One of the primary causes of the HP phenotype in AIVs is 
the acquisition of a multi- basic cleavage site (MBCS) in the 
haemagglutinin (HA) protein that facilitates systemic infec-
tion. The MBCS allows for HA to be proteolytically activated 
by ubiquitous intracellular furin- like serine proteases such as 
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would ordinarily be activated by trypsin- like proteases that 
are restricted to respiratory or intestinal epithelia [18]. Such 
viruses would typically carry a low pathogenic (LP) pheno-
type. However, the existence of an MBCS does not guarantee 
a HP phenotype. Indeed, experiments that artificially intro-
duce an MBCS into H1, H3, H10 and H11 show these virus 
subtypes to be refractive to a HP phenotype [19, 20].
Early investigations into the phenotype of H5 viruses carrying 
an MBCS showed differences in pathogenesis between 
different avian hosts and various degrees of virulence and 
capacities to transmit by contact to naive birds [21]. In these 
initial investigations, ducks were shown to be resistant to 
infection, one H5N1 virus, A/chicken/Scotland/59 was shown 
to be pathogenic in chickens but not turkeys, and a H5N9 
virus, A/turkey/Ontario/7732/66 was shown to be pathogenic 
in turkeys but not chickens [21]. H5N1 viruses with an HP 
phenotype in ducks have been isolated on several occasions 
and the amino acid residues shown to facilitate this HP 
phenotype have been shown to exist on multiple influenza 
genes, including HA, albeit at residues distal to the MBCS 
[22, 23]. Taken together, it is evident that the transition of an 
AIV from an LP to an HP phenotype is complex and involves 
several virus factors beyond the MBCS.
Prior to the emergence of the GsGd lineage, an H5N1 virus, 
namely A/turkey/England/50- 92/1991 (50- 92), was isolated 
in late 1991 from a devastating outbreak in farmed turkeys in 
England. The virus 50–92 was shown to have an intravenous 
pathogenicity index (IVPI) score of 3.0, confirming it to be an 
HPAIV [21]. Interestingly, plaque clones in MDCK cells were 
isolated and shown to have either an LP or an HP phenotype, 
and potential causative substitutions were identified in the HA 
gene [24]. The three amino acid residues that differed were at 
positions 160, 193 (H3 numbering used throughout) close to 
the receptor binding pocket and the fourth amino acid of HA2 
(HA24 or H5 aa residue 348) in the fusion peptide; both LP 
and HP viruses retained the MBCS. A second H5N1 virus (A/
turkey/England/87- 92/1991) was isolated from this outbreak 
and shown to have an IVPI of 0.00 [24]. This virus was similar 
to the 50–92 virus in that it shared the same amino acids at 
residues 193 and HA24; it differed from 50 to 92 at amino 
acid residue 160. We hypothesised that the three substitutions 
present in the 50–92- HP clones (160T, 193K, HA24R) in the 
HA gene were required for efficient HA binding, and fusion. 
In this study, we aimed to generate variants of the 50–92 virus 
at all three HA positions and elucidate the mechanism by 
which these amino acids can alter the pathogenesis of H5N1 
virus 50–92 in the chicken host.
METHODS
Cells and eggs
Chicken embryo fibroblast (CEF), human embryonic 
kidney (293T), chicken fibroblast (DF- 1), Madin- Darby 
canine kidney (MDCK) and human epithelial (HeLa) cells 
were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM; Invitrogen) supplemented with 10 % foetal calf 
serum (FCS) (Biosera) and 1 % penicillin- streptomycin 
(PS; 100× stock at 10 000 IU Penicillin and 10 000 µg ml−1 
Streptomycin). The cell lines were maintained at 37 °C in a 
5 % CO2 incubator. DF- 1 cells were maintained at 39 °C. Cell 
lines were trypsinised and passaged twice weekly. CEF cells 
were generated from 9 to 10 day old chicken embryos using 
0.25 % trypsin (Invitrogen) [25]. Virus was grown in 10 day 
old specific- pathogen- free (SPF) embryonated hens’ eggs 
which were monitored daily by candling. Eggs infected with 
HPAIV were monitored routinely and chilled ideally at the 
point where the integrity of egg veins were decreasing, and 
embryo viability was dropping. However, in some instances 
eggs were chilled when death had already occurred. LPAI 
infected eggs were chilled after 2 to 3 days- post- infection 
(dpi). Allantoic fluid was harvested using sterile technique 
and stored at −70 °C.
Recombinant virus and site-directed mutagenesis
The reverse genetics system for generation of recombinant A/
turkey/England/50- 92/1991 (H5N1) (50- 92) virus has been 
described previously [26]. Mutagenesis of the 50–92 HA gene 
was carried out sequentially to introduce each of the three HA 
substitutions and removal of the HA multi- basic cleavage site 
for sb50- 92 viruses using the QuikChange Lightning Site- 
Directed Mutagenesis Kit. The 50–92, 50- 92160T 50- 92160T,193K, 
50- 924R and 50–92- HP HA genes were successfully inserted 
into the pCAGGS expression vector via the introduction of 
the NotI and MluI restriction enzyme sites on the 5′ and 3′ 
ends by PCR. All plasmid constructs were verified by DNA 
sequencing and all virus HA substitutions were verified by 
sequencing the mutated region of the viral gene of success-
fully generated reverse- genetics (RG) virus.
In vitro virus growth kinetics
Influenza viruses were first titrated by plaque assay; see section 
Visualisation of plaque morphology in MDCK cells. Plaques 
were counted and used to determine the plaque forming 
units per millilitre of virus. This was then used to achieve the 
desired multiplicity of infection (MOI). CEF cells in 6- well 
plate format were inoculated at a MOI of 10−3, washed once 
in PBS and incubated in 2 ml DMEM supplemented with 2 % 
FCS and 1 % PS at 37 °C. At the times indicated, cell superna-
tant was collected, vRNA isolated using the Qiaquick RNA 
extraction method (Qiagen) as previously described [27], 
and viral RNA determined by qRT- PCR. Briefly, viral RNA 
was quantified by influenza Matrix (M gene) qRT- PCR, as 
previously described [28]. Relative EID50 units (REU) were 
calculated by quantitative standards of five ten- fold dilutions 
of extracted RNA from 106 EID50 A/turkey/Turkey/1/2005 
[27]. Not detected (negative) samples were deemed so if they 
held a ct value of more than 35–36, depending on the ct values 
observed for the negative and positive controls included in 
the qRT- PCR run. For each qRT- PCR the negative control 
included the RNase- free water used to dilute the PCR reac-
tion, and the positive control included vRNA at a known 
concentration that was extracted at the same time as the RNA 
isolation of the samples to be tested.
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Visualisation of plaque morphology in MDCK cells
Confluent monolayers of MDCK cells in 12- well plates were 
prepared for infection beforehand. Virus was diluted in SF 
DMEM in a ten- fold dilution series. Cell monolayers were 
washed with PBS, PBS was then removed and inoculated with 
200 µl of virus and incubated at 37 °C for 1 h. Following inocu-
lation, 1 ml of flu overlay and avicel (Sigma Aldrich) mix (2 : 1 
ratio) with or without 1µg ml−1 TPCK trypsin (Sigma Aldrich) 
was added to each well [29]. After 3 days incubation at 37 °C, 
the overlay was removed, and cells fixed/stained using 0.1 % 
crystal violet solution (1 % crystal violet in water (Sigma- 
Aldrich Cat. No. HT901- 8FOZ), 20 % methanol). Monolayers 
were washed before imaging using a flatbed scanner.
Animal studies
For the IVPI tests, all procedures were conducted in accord-
ance with OIE guidelines [30]. Briefly, ten 6- week- old White 
Leghorn chickens, hatched from eggs obtained from a SPF 
flock, were intravenously infected with a minimum of 16 
haemagglutination units (HAU) of virus diluted one in ten in 
sterile PBS. Clinical signs were scored in accordance with the 
IVPI test and recorded daily for 10 days, after which, surviving 
birds were humanely killed. Oropharyngeal, cloacal and blood 
samples were taken from all chickens prior to infection to test 
for current and previous influenza infection. Samples revealed 
no current infection with H5N1 by M gene qRT- PCR and no 
previous exposure to H5N1 infection by haemagglutination 
inhibition antibody testing [30] using A/turkey/England/50-
 92/91 antigen (APHA, Weybridge).
Split venus HA fusion assay
Confluent 6- well plates of cells were transfected with 1250 ng 
pCAGGS 50–92 HA or empty pCAGGs together with 1250 ng 
pBiFC- bJunVN155 or with 1250 ng of pBiFc- bFosVC155 
alone [31]. Three hours after transfection, cell monolayers were 
washed in serum free DMEM and trypsinised before mixing 
the HA+pBiFC- bJunVN155 cells with the pBiFC- bFosVC155 
cells in a 1 : 1 ratio and seeding into clear bottomed black sided 
96- well plates (Corning). After 24 hours cells were washed 
with 100 µl pre- warmed serum free DMEM and treated 
with 100 µl MES pH buffer at the indicated pH at 37 °C for 
5 min before cell media was replaced. After 3 h syncytia were 
imaged by fluorescence microscopy. Fluorescence intensity 
of cells was measured with a FLUOstar Omega plate reader 
(BMG Labtech).
pH stability of 50-92 H5 pseudotyped virus like 
particles
The 50–92 HA pseudotyped viruses (PVs) encoding firefly 
luciferase were generated in HEK 293 T cells and treated with 
exogenous NA (Sigma Aldrich) as previously described [32, 
33]. Then 50 µl of PV stock was mixed gently with an equal 
volume of pre- warmed MES pH buffer at the indicated pH 
in 1.5 ml Eppendorf tubes and incubated at 37 °C for 5 min 
before inoculation of 25 µl per well of confluent HEK 293 T 
cells in a white bottomed 96- well plate. After 24 hours cell 
media was removed, and cells were lysed in passive lysis buffer 
(Promega) before quantification using a firefly Luciferase 
Assay System (Promega) and a FLUOstar Omega plate reader 
(BMG Labtech).
Biolayer interferometry
Viruses were propagated in embryonated hen’s eggs and 
concentrated by centrifugation at 135 000 g for 2 h at 4 °C. 
Concentrated virus was then resuspended in PBS and puri-
fied using a 30–60 % continuous sucrose gradient at 135 000 g 
for 2 h at 4 °C. Purified virus was recovered from the sucrose 
gradient and centrifuged a final time to form a pellet which 
was resuspended in PBS. Purified virus was then quantified 
by NP- ELISA. Virus was serially diluted two- fold in PBS and 
adsorbed to Immulon 2HB (Thermo: 10795026) plates over-
night at 4 °C. Plates were then blocked with blocking buffer 
(5 % skimmed milk powder, 0.1 % Tween- 20) for 1 h at room 
temperature, washed with washing buffer (0.1 % Tween- 20) 
then viruses permeabilised with 0.2 % (v/v) Triton X- 100 in 
PBS at room temperature for 30 min. Plates were then washed 
with washing buffer and incubated with mouse anti- influenza 
A NP mAb (in house) for 1 h at room temperature. Plates were 
washed again with washing buffer then incubated with HRP- 
conjugated goat anti- mouse IgG for 1 h at room temperature. 
Plates were washed a final time before substrate solution was 
added, followed by 0.1 M H2SO4 to stop the reaction. The 
plate was read at 450 nm and absorbance values for sample 
virus were compared to a purified SDS- PAGE quantified 
control virus (X- 31). Absorbance values were plotted against 
Log10[virus] using Graphpad Prism. A curve was fitted using 
the sigmoidal dose response (variable slope) function. The 
Log10[virus] of sample virus was determined by interpolating 
absorbance values using the X- 31 standard. Binding of puri-
fied virus to biotinylated sialic acid receptor analogues, α2,6- 
sialyllactosamine (6SLN), α2,3- sialyllactosamine (3SLN), 
and Neu5Ac α2,3 gal β1–4(6- HSO3) GlcNAc (3SLN(6Su)) 
(GlycoNZ, Auckland, New Zealand), was measured by 
biolayer interferometry using an Octet RED instrument 
(Sartorius), and established methods [34]. Streptavidin- 
coated biosensors (Sartorius) were used to immobilise 
biotinylated receptor analogues at a concentration range of 
0.01 to 0.5 µg ml−1 in 10 mM HEPES, pH 7.4, 150 mM NaCl, 
3 mM EDTA and 0.005 % Tween- 20 (HBS- EP). Virus was 
diluted to a concentration of 100 pM in HBS- EP consisting 
of 10 µM oseltamavir carboxylate (Roche, Welwyn Garden 
City, UK) and zanamivir (Sigma- Aldrich, Gillingham, UK). 
Association between virus and receptors was measured over 
30 min at 20 °C, and the relative amount of virus bound to the 
biosensor via the receptor analogues at the range of receptor 
analogue concentrations was calculated using the amplitude 
of the response at the end of the association step.
Immunohistochemistry and flow cytometry
For immunohistochemistry (IHC), 293 T cells were trans-
fected with 500 ng 50–92 HA pCAGGS plasmid on glass 
coverslips and incubated for 24 h. Cells were fixed in 4 % 
paraformaldehyde in PBS and probed with sheep α-HA 
antibody (1 : 300) (Vietnam/04, NIBSC) and HA indirectly 
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detected by goat α-sheep antibody conjugated to FITC (1 : 500) 
(Merck Millipore). Pictures of fluorescent cells were acquired 
with an Axiovert 200M microscope (Zeiss) with a Axiocam 
HRC camera (Zeiss) and were edited with AxioVision Rel 4.7 
programme. For flow cytometry, HeLa cells in 12- well plate 
format were transfected with 500 ng of pCAGGS plasmid 
expressing 50–92 HA and incubated for 24 h. After 24 h 
incubation, cell supernatants were removed and cells were 
trypsinised, pelleted by brief centrifugation in 1.5 ml Eppen-
dorf tubes, and resuspended and washed in ice- cold PBS then 
probed with chicken polyclonal anti- 50–92 HA sera (1 : 100) 
(APHA, Weybridge). HA was indirectly detected by Alexa-
Flour 488 FITC antibody (1 : 500). Prior to flow cytometry 
analysis, cells were fixed with 1 % paraformaldehyde in PBS 
for 10 min on ice. Cells were analysed using a MACSQuant 
flow cytometer (Miltenyi biotec) and data analysed using 
FACS Quant software.
RESULTS
Mapping amino acid substitutions on the H5 
haemagglutinin crystal structure
The three HA amino acid residues found to be mutated 
between LP and HP 50–92 virus were mapped onto the 
crystal structure of an H5 HA to determine their proximity 
to important functional regions of HA (Fig. 1). Residues 160 
and 193 are located on the head of HA1 close to the receptor 
binding pocket formed by the 130- loop, 150- loop, 190- helix 
and 220- loop (Fig. 1b). Residue 160 is adjacent to the promi-
nent 150- loop while residue 193 is adjacent to the 190- helix 
at the rim of the receptor binding pocket. Residue HA24 
is located on the fusion peptide (Fig. 1a, b). The identified 
amino acid residues in the head domain of HA are exposed 
where they can interact with their local environment whereas 
the fusion peptide amino acid residue is partially occluded 
within the trimer interface of the HA protein (Fig. 1c). The 
amino acid substitution at residue 160 from alanine (A) to 
threonine (T) introduces an N- linked glycosylation motif; the 
resulting glycan at residue 158 would therefore protrude from 
the 150- loop and be close to the receptor binding pocket. 
Glycosylation of H5N1 HA residue 158 has been confirmed 
previously [35].
Generating HP 50-92 reverse genetics virus
To study the contribution of the identified HA amino 
acid substitutions to the phenotype change in the highly 
pathogenic 50–92 virus, we used reverse genetics to generate 
recombinant wild- type (WT) 50–92 virus [26] with changes 
introduced into the HA using site- directed mutagenesis. 
Virus containing single substitutions at residue 160 or 193 
could not be generated despite multiple attempts indicating 
that in isolation these substitutions are detrimental to virus 
biology. Amino acid substitutions A160T, glutamate (E) to 
lysine (K) at residue 193 and glycine (G) to arginine (R) at 
residue HA24 were introduced. The result was an isogenic HA 
relative to a highly pathogenic 50–92 clone described by [24]. 
We also generated viruses carrying various combinations of 
the amino acid identities; thus, viruses containing A160/
E193/HA2G4 (50–92), A160T/E193K/HA2G4R (50–92- HP), 
A160T/E193K (50- 92160T,193K), A160T/HA2G4R (50- 92160T,4R), 
E193K/HA2G4R (50- 92193K,4R) and HA2G4R (50- 924R) were 
generated. All viruses retained their MBCS in HA and the 
remaining gene segments were from wild- type 50–92.
Small differences in virus replication detected 
between 50-92 variant viruses in avian cells
To determine the impact of the HA amino acid substitu-
tions on virus replication we performed in vitro multi- cycle 
virus replication kinetics experiments in primary chicken 
embryonic fibroblast (CEF) cells using each of the 50–92 
viruses generated above. At 8 and 28 h post- infection there 
were no statistically significant differences between viral 
RNA detected in cell supernatants. However, at 20 h post- 
infection all viruses apart from 50- 92193K,4R demonstrated 
small but statistically significantly increased levels of viral 
RNA compared to 50–92 (Fig.  2a). Interestingly, E193K 
enhanced virus replication when in combination with A160T 
but not HA2G4R alone, which suggests an optimal combina-
tion of substitutions affected virus replication. As seen with 
the 50–92 clones described by Wood et al., virus plaque 
morphologies differed between 50–92 variants (Fig.  2b). 
Fig. 1. Location of amino acid substitutions on crystal structure of H5 
HA. The three amino acid residues identified to differ between LP 50–
92 and HP 50–92 were visualised on the crystal structure of H5 HA 
(PDB: 5E34) [55] using PyMol [56]. (a) Cartoon representation of H5 HA 
monomer with HA1 shown in blue and HA2 shown in pale blue. Residues 
160, 193 and HA
2
4 are shown in red as sphere representations. (b) The 
head domain of HA1 is shown in blue with components of the receptor 
binding pocket, the 130- Loop, 150- Loop, 190- Helix and 220- Loop. A 
receptor analogue (LSTa) of 2,3 sialic acid is shown in green in the 
receptor binding pocket. (c) A trimer of the HA protein is shown, with a 
focus on the fusion peptide.
5
Sealy et al., Journal of General Virology 2021;102:001672
The virus 50- 92193K,4R showed strikingly small pin- prick virus 
plaques despite a comparatively modest reduction in vRNA 
titres when compared to the other 50–92 viruses (Fig. 2b).
Contribution of A160T, E193K and HA2G4R to a 
highly pathogenic phenotype in chickens
Next, we wanted to determine virus pathogenicity in 
6 week old chickens using the IVPI test. We were able to 
test 50–92, 50- 92160T,193K and 50–92- HP. These three viruses 
gave IVPI scores of 0.02, 0.68 and 2.88, respectively. Thus, 
only 50–92- HP containing the A160T, E193K and HA2G4R 
substitutions maintained a HP phenotype as defined by the 
IVPI test. The virus 50- 92160T,193K led to a greater number of 
clinical signs in chickens compared to 50–92, which peaked 
at day six post- inoculation, although no birds succumbed to 
the infection (Fig. 3a). There was limited viral RNA detected 
for both 50–92 and 50- 92160T,193K, although some viral RNA 
was detected in cloacal swabs from several birds infected with 
50- 92160T,193K virus (Fig. 3b, c). The 50–92- HP viral RNA was 
detected in all birds by oropharyngeal and cloacal swabbing 
day one post- infection at significantly higher levels compared 
to 50–92 and 50- 92160T,193K, together with the most severe 
clinical signs, with all birds succumbing to infection by day 
two post- infection.
Amino acid substitution HA2G4R increases the pH of 
fusion
Due to the location of the HA2G4R amino acid substitution 
on the fusion peptide we hypothesised that this may alter 
the pH of fusion and could account for the increased patho-
genesis in chickens. To this end, we employed a bimolecular 
fluorescence complementation assay to measure HA cell to 
cell fusion in human 293T and chicken DF- 1 cells comparing 
the impact on pH of fusion by the HA substitutions. Each of 
the 50–92 HAs were cloned into pCAGGS expression plas-
mids and transfected into cells along with the bZIP domain 
containing Jun protein tagged with the N- terminal half of 
Venus or with Fos tagged with the C- terminal half of Venus 
protein alone (Fig. S1). At 3 h post- transfection the two 
cell populations were mixed and incubated for 24 h before 
being treated with MES pH buffers to activate HA fusion. 
Successful HA fusion of HA at the cell surface resulted in 
syncytia formation that permitted the mixing of Jun and 
Fos and the subsequent complementation of Venus protein 
that was imaged by fluorescence microscopy (Fig. 4a, b). 
Fluorescence intensity was measured using a plate reader 
(Fig. 4c, d). The virus 50- 924R HA displayed the highest pH 
of fusion with appreciably more fusion seen at pH 5.5 in both 
293T and DF- 1 cells compared to any other HA, although 
this was more pronounced in DF- 1 cells (Fig. 4). WT 50–92, 
50- 92160T and 50- 92160T,193K all displayed a peak in fusion at 
pH between 5.0 and 5.3 in both cell types with a dramatic 
drop in fusion by pH 5.4. The 50–92- HP showed an inter-
mediate pH of fusion with a pronounced increase in DF- 1 
cells whereby there was appreciable fusion at pH 5.5, albeit 
to a lesser extent than 50–92 with the HA2G4R substitu-
tion alone. Both 50- 92160T and 50- 92160T,193K HAs caused less 
intense fluorescence in DF1 cells compared to WT 50–92 or 
HAs containing the HA2G4R substitution. Taken together 
these data suggest the two substitutions close to the receptor 
binding pocket, A160T and E193K, reduce the pH of fusion 
and the substitution in the fusion peptide increases the pH 
of fusion (Fig. 4).
Fig. 2. Virus replication kinetics and plaque morphology of 50–92 H5 viruses. (a) CEF cells were infected with 50–92 H5N1 viruses (MOI 
0.0001), incubated at 41 °C and cell supernatants harvested at 8, 20 and 28 h post- infection. vRNA was extracted from cell supernatants 
and quantified by qRT- PCR of M gene (REU=Relative EID
50
 Unit). Error bars are SEM. Statistical analysis by two- way ANOVA with Dunnett’s 
multiple comparisons test. ns=not significant, **P<0.001, ****P<0.00001. (b) Plaque assay of MDCK cells infected with a serial dilution of 
H5N1 virus in the absence of TCPK trypsin. Cells were fixed, stained and imaged using a flatbed scanner.
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Fig. 3. HA substitutions A160T, E193K and HA
2
G4R were required for highly pathogenic phenotype of H5N1 50–92 virus in chickens. 
IVPI testing was performed for 50–92, 50–92- HP and 50- 92
160T,193K
 virus where ten 6 week old SPF chickens were intravenously injected 
with >16 HA units of virus. (a) Birds were scored for clinical signs throughout 10 days (0=normal, 1=sick, 2=severely sick, 3=dead). The 
50–92 data points are shown as circles, 50–92- HP as triangles, and 50- 92
160T,193K
 as diamonds. Oropharyngeal (b) and cloacal (c) swabs 
were taken from five randomly selected birds 1 day post- infection (dpi) and 11 dpi († except 50–92- HP where birds succumbed to 
infection at 2 dpi). Viral RNA was extracted and quantified by qRT- PCR of M gene (REU=Relative EID
50
 Unit). Error bars are SEM. Statistical 
analysis of 1 dpi by one- way ANOVA with Tukey’s multiple comparisons test, 11 dpi by unpaired two- tailed t- test. ns=not significant, 
*P<0.01.
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Amino acid substitution HA2G4R reduces pH 
stability
To extend our studies on the impact of HA2G4R on pH 
of fusion we conducted pH stability assays using influ-
enza PVs, as a safer alternative to HPAIVs [32]. The PVs 
were treated with MES buffers at various pH values and 
inoculated onto 293 T cells. The rationale was that PVs 
with reduced pH stability would have reduced capacity to 
infect cells due to premature fusion- activation, quantified 
by measuring luciferase expression from successfully 
transduced PVs. A PV was generated using the envelope 
protein of amphotropic murine leukaemia virus (A- MLV), 
whose cell entry is pH- independent, and was used as a 
control. The two PV containing the HA2G4R substitution, 
50–92- HP and 50- 924R, had significantly reduced capacity 
to infect cells at  >pH 5.4 whereas all other viruses did not, 
suggesting these PV were less pH stable (Fig. 5). Interest-
ingly, 50- 92160T significantly increased its capacity to infect 
cells at >pH 5.4. These data corroborate what was seen with 
the pH of fusion data (Fig. 4) whereby A160T and E193K 
in the receptor binding pocket increase pH stability and 
HA2G4R on the fusion peptide reduce pH stability; together 
these substitutions optimise pH stability. We confirmed that 
each substitution studied did not alter the pCAGGS driven 
expression of HA in cells (Fig. S1, available in the online 
version of this article).
Amino acid substitutions A160T and E193K 
modulate receptor binding
Due to the proximity of the A160T and E193K amino acid 
substitutions to the receptor binding pocket we wanted to 
investigate their impact on virus receptor binding. To this 
end we reconstructed the reverse genetics 50–92 viruses to 
exclude the MBCS and to contain H1N1 PR8 internal genes 
in order to conduct biolayer interferometry. These viruses 
were named single- basic 50–92 (sb50- 92). Interestingly, 
by taking this approach we were able to generate viruses 
with the single substitutions of A160T and E193K in addi-
tion to the A160T/E193K double mutant. These sb50- 92 
viruses (including sb50- 92 with A160 and E193 residues) 
were purified and used in biolayer interferometry to assay 
receptor binding phenotype. We assayed receptor binding 
against avian- like 3′-sialyllactosamine (3SLN), human- like 
6′-sialyllactosamine (6SLN) and a sulphated version of the 
avian- like 3SLN called 3SLN(6Su), which are commonly 
used analogues of host cell 2,3 and 2,6 sialic acid (SA) [36, 
34]. When taken in isolation, the E193K substitution had 
the largest impact on receptor binding, facilitating a 46- fold 
increase in binding to 3SLN(6Su) and a six- fold increase in 
binding to 3SLN relative to sb50- 92 with A160 and E193 
(Fig.  6, Table  1). Furthermore, in isolation the A160T 
substitution facilitated an eight- fold increase in binding to 
3SLN(6Su) but a three- fold decrease in binding to the non- 
sulphated analogue, 3SLN (Fig. 6, Table 1). Together, the 
A160T/E193K substitutions facilitated a 23- fold increase 
in binding to 3SLN(6Su), and an eight- fold increase in 
binding to 3SLN (Fig. 6, Table 1). The reduced binding of 
A160T/E193K to 3SLN(6Su) relative to E193K indicates the 
addition of an N- linked glycan at residue 158 optimizes, by 
decreasing, the significant increase in binding facilitated by 
E193K alone. There was no detectable binding to 6SLN by 
any of the viruses tested.
Natural occurrence of identified substitutions
Finally, we wanted to determine the natural occurrence of 
each amino acid at residues 160, 193 and HA24 studied here. 
Fig. 4. Substitution HA
2
G4R decreased pH of fusion of H5 HA expressed 
in human 293T and chicken DF- 1 cells. Split venus fluorescent HA fusion 
assays were conducted in 6- well plates of 293 T cells (a) or DF- 1 cells 
(b). Cells were transfected with 1250 ng pCAGGS 50–92 HA or empty 
vector together with 1250 ng pBiFC- bJunVN155- or 1250 ng pBiFC- 
bFosVC155 alone and after 3 hours cell populations were mixed and 
split into 96- well plates in a 1 : 1 ratio. After 24 hours cells were treated 
with MES pH buffer at the indicated pH at 37 °C for 5 min before cell 
media was replaced. After 3 h syncytia were imaged by fluorescence 
microscopy. Fluorescence intensity of 293 T cells (c) and DF- 1 cells (d) 
was measured using a plate reader (RLU=relative light unit).
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We also extended our analysis to include residues 158 and 
159 to incorporate the full N- linked glycosylation motif 
associated with residue 160 (Table 2). For avian H5N1 HA, 
61 % of sequences contained an N and 36 % contained a D 
at residue 158. Furthermore, at HA 160, 63 % of sequences 
contained an A, 35 % a T and <1 % an S (Table 2). Taken 
together 32 % (n=975) of avian H5N1 HA sequences carry 
a potential N- linked glycosylation motif between residues 
158 and 160. For human H5N1 HA, 81 % of sequences 
contained an N and 17 % a D. At HA 160, 34 % of sequences 
contained an A, 63 % a T and 1.6 % an S (Table 3). Taken 
together 64 % (n=277) of human H5N1 HA sequences carry 
a potential N- linked glycosylation motif between residues 
158 and 160. We found HA 193 was highly conserved with 
a preference for a positively charged amino acid, K (53 and 
59 %; human and avian) or R (44 and 34 %; human and 
avian), suggesting a selective pressure exists for a positively 
charged amino acid in H5N1 HA protein at this residue. 
We identified total conservation of G at HA24 in human 
H5N1 viruses and almost total conservation in avian H5N1 
viruses; there was one virus with A and one virus with 
R at HA24.
DISCUSSION
We sought to examine which of the three HA amino acid 
differences in 50–92 HA were responsible for a change in 
virus pathogenesis. We found all three HA substitutions 
were necessary for the HP phenotype and increased virus 
shedding in chickens. Reverse genetics generated WT 50–92 
was severely attenuated with negligible shedding detected in 
vivo, suggesting the original consensus sequence of the virus 
isolate from this HP outbreak in turkeys did not account 
for the pathogenic phenotype, and the clones discovered in 
the original quasispecies must have been responsible for the 
observed pathogenesis [24]. The combination of 160T and 
193K alone failed to confer the HP phenotype in chickens, 
although there was some evidence that they might have 
contributed to increased replication in vivo. Substitution 
HA2G4R was necessary to complete the transformation into 
Fig. 5. Substitution HA
2
G4R decreased pH stability of H5 pseudotypes. Infection of HEK 293 T cells with 50–92 H5 pseudotypes encoding 






, 50–92- HP VLPs were mixed with an equal volume of MES pH buffer 
(7.4, 5.6, 5.5, 5.4, 5.3, 5.0) at 37 °C for 5 min and inoculated onto 293 T cells in 96- well plates in triplicate. A- MLV pseudotype was treated 
similarly, as a pH independent entry control. After 24 hours cells were lysed in passive lysis buffer and firefly luminescence quantified 
and measured by a plate reader. Data were normalised to % relative light unit (RLU) of VLPs treated at pH 7.4. Data points are shown as 
squares for 50–92, upward triangles for 50- 92
160T
, downward triangles for 50- 92
160T, 193K
, diamonds for 50- 92
4R
, filled circles for 50–92- 
HP, and empty circles for the A- MLV control. Statistical analysis by two- way ANOVA with Dunnett’s multiple comparisons test, ns=not 
significant, *P<0.1, ***P<0.001, ****P<0.0001.
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an HPAIV. We did not determine whether HA2G4R was 
capable of the HP phenotype alone, and whether substi-
tutions 160T and 193K were indeed required for the HP 
phenotype. However, SA binding analysis together with 
bioinformatic analysis suggests there is a strong preference 
for a charged amino acid at residue 193 as is typically found 
in H5N1 viruses.
H5N1 50–92 carries a short- stalk (ss) NA due to a 22aa deletion 
which could be linked to the need for a glycan at residue 158. HA 
lacking a glycan at 158 restricts virus growth when combined 
with a ssNA [37]. When a long- stalk NA is combined with a 
glycosylated 158 there is poor virus growth. Intriguingly, for 
50–92 virus, the 193K substitution was detrimental for 50–92 
virus in combination with HA2G4R alone, resulting in a small 
plaque size and reduced growth compared to 50–92- HP. This 
is likely due to reduced virus release, since 193K significantly 
increases binding, and the lack of a glycosylation site to sterically 
block SA binding results in an ‘overactive’ HA. When 160T is 
added alongside 193K the dramatic increase in binding avidity 
driven by 193K alone is somewhat ameliorated by the additional 
glycan. The contribution of N- linked glycans in the HA protein 
to pathogenesis has been studied for several HP viruses. In an 
H7N7 virus, the addition of a glycan to the head region of HA1 
Fig. 6. Receptor binding profiles of H5N1 50–92 virus. Biolayer 
interferometry was used to determine the impact on receptor binding 
of three amino acid substitutions in the HA protein. The impact of 
substitutions was determined for both α2,3- sialyllactosamine (3SLN) 
(a) and Neu5Ac α2,3 Gal β1- 4(6- HSO3)GlcNAc (3SLN(6su)) (b). Blue 
lines with squares show binding of sb50- 92, red circles of sb50- 
92
160T,193K
, purple upward triangles of sb50- 92
E193K
, and black downward 
triangles of sb50- 92
160T
. There was no detectable binding to the receptor 
analogue α2,6- sialyllactosamine (6SLN).
Table 1. Fold- changes in receptor binding
Fold- change binding per sugar
H5N1 50–92 variants 3SLN(6Su) 3SLN
sb50- 92 (A160, E193, G4) na na
sb50- 92160T 8× increase 3× decrease
sb50- 92193K 46× increase 6× increase
sb50- 92160T,193K 23× increase 8× increase
Table 2. Percentage frequency of amino acids at the studied residues 
for avian H5N1 viruses
Full- length nucleotide sequences of H5N1 avian (n=2997) were 
downloaded from the NCBI database and analysed to determine the 





158 159 160 193 HA24
Amino acid
N 61.90 62.90 – 1.07 –
D 36.70 15.68 – 0.70 –
R – – – 59.03 0.03
A – 0.40 63.26 – 0.03
Q – – – 0.57 –
E 0.03 – 0.03 0.23 –
G 1.00 0.30 – 0.30 99.93
H – 0.03 – – –
I – – 0.13 – –
K – – 0.03 34.80 –
M – – 0.13 2.37 –
S 0.37 20.62 0.73 0.10 –
T – 0.07 35.67 0.83 –
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was shown to recover the HP phenotype in chickens compared 
to an LP variant that lacked the glycosylation site [38].
Interestingly, neither 160T nor 193K, nor combinations thereof 
facilitated virus binding to human- like 2,6 SLN. Despite this, 
amino acid substitutions close to the receptor binding pocket of 
H5N1 HA have previously been shown to promote human- like 
2,6 SLN binding [39, 40]. We also confirmed the importance 
of the sulphated 2,3 sialic acid analogues to AIVs of the H5N1 
subtype; all viruses tested here showed receptor binding to both 
non- sulphated and sulphated analogues. This suggests that the 
160T and 193K in the context of this H5N1 virus does not 
heighten the risk of zoonotic infection and in fact reinforces 
poultry adaptation when taking into account the HA24R substi-
tution [41–44]. It is likely these substitutions are required for 
efficient viral binding and release in the chicken host.
Bioinformatic analysis highlighted the novelty of the HA2G4R 
substitution; almost all H5N1 viruses contain a non- polar G 
at HA24 whereas the HA2G4R amino acid substitution studied 
here represents a swap of G for positively charged R. We are 
not aware of previous descriptions of the effects of the HA2G4R 
substitution in the literature. Instead a G4A substitution has 
been studied and shown to increase the pH of fusion by 0.4 pH 
units [45]. In addition, removal of the negative charge in the 
fusion peptide has been shown to result in deeper penetration 
of the fusion peptide into the host cell membrane [46]. This 
observation may suggest that the HA2G4R substitution could 
result in deeper penetration of the fusion peptide, allowing 
fusion to occur at a higher pH. Introducing either 160T or 193K 
resulted in a reduced pH of fusion compared to WT 50–92. The 
pH of fusion was recovered by the HA2G4R substitution, to a 
level more usual for avian viruses, around pH 5.5 [43, 47–49].
Receptor binding mutations have previously been described to 
alter the stability of the HA. The H5 HA of Vietnam/04 was 
adapted for ferret respiratory droplet transmission by Imai 
et al. [50]. The introduction of receptor binding mutations 
N224K/Q226L increased the pH of fusion compared to WT 
HA. Removal of a glycosylation site, N158D, did not appear to 
alter pH of fusion further. To compensate this change in pH a 
fourth mutation was selected, T318I which stabilized the HA, 
and decreased pH of fusion either alone or in combination with 
the receptor binding mutations. Since human viruses have been 
shown to require a lower pH of fusion than avian- restricted 
AIVs, the T318I mutation was required to correct the nega-
tive effect of the receptor switching mutations. Previously, a 
similar set of mutations described a HA mutation likely to alter 
pH of fusion, H103Y, although this was not confirmed [51]. 
Clearly all three sets of mutations were required together to 
adapt 50–92 HA for increased pathogenicity in poultry, and the 
function described by each of these mutations is remarkably 
like those described for the two H5 viruses that were adapted 
to ferrets.
Likewise, a previous study found that H5 H24Q substitution 
decreased pH of fusion to promote efficient transmission 
in ferrets when coupled with receptor binding changes 
and a loss of an N- linked glycan at residue 158 [52]. Thus, 
H5 viruses offer an interesting model for studying virus 
mechanisms of pathogenesis beyond the MBCS and under-
standing the interplay of pathogenesis, species- specificity, 
and transmission.
The pH of HA fusion has previously been linked to pathogen-
esis in the avian host. A panel of H5N1 viruses that ranged in 
their pH fusion demonstrated an increase in pathogenicity in 
chickens that correlated with an increase in the pH of fusion 
[47]. Similar experiments in ducks described an optimal pH of 
fusion that when decreased resulted in decreased pathogenicity, 
but when increased further the unstable HA was detrimental 
to virus transmission [49]. This observation prompted the 
intriguing hypothesis that selection of unstable HAs may 
increase pathogenesis but at the cost of efficient transmission, 
whereby such AIVs may not be spread further via wild birds 
[53]. The mechanism underlying the increase of pathogenesis 
by a pH unstable HA remains to be understood, although the 
potent host factor Interferon- Inducible Transmembrane Protein 
3 (IFITM3) has been suggested as a possible driver for this 
adaptation. Chicken IFITM3 prevents virus entry by blocking 
virus HA fusion with the late endosomal membranes and it is 
suggested that viruses may evade this factor by fusing at a higher 
pH in the earlier endosome membranes [54].
The amino acid substitutions described by this work highlight 
a route to increased pathogenicity by mutations accumulating 
in HA including a novel mutation that affects pH of fusion. In 
summary, these data provide useful information for under-
standing virulence mechanisms of H5N1 viruses for poultry 
and contribute to the concept of pH as a virulence factor and 
interspecies host barrier for influenza virus.
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